SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #2,631CAS 2区Hybrid

Targeted Oncology

Abbreviation (ISO):TARGET ONCOL
Country: France•WoS SCIE Quartile: Q1•Scopus SJR: 1.435•SCImago Rank: #2,631•Identifier (ISSN):1776-2596(Print)/1776-260X(Online)•Articles / Year: 67•Estimated Publication Fee (APC): $3,560 USD
Clarivate IF (2026)Q1
5.1
↑ +1.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
35

35 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
67articles/year
50.46% Gold OA•74.19% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 5.1)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.1)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 4)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.4)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.4)
🔵 Computed
20222.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.864)
🔵 Computed
20212.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.493)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.036)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.683)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.877)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Targeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes: Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches. Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways. Current Opinion articles that place interesting areas in perspective. Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations. Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement. Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.

Topics Covered (Recognized by AI)
Medicine99.8%Biology97.9%Internal medicine96.7%Genetics94.1%Cancer78.9%Oncology73.7%Pathology68.8%Chemistry60.8%Biochemistry52.4%Surgery50.6%Cancer research46.5%Immunology36%Chemotherapy32.6%Pharmacology28.8%Bioinformatics27.4%Gene26.3%Receptor24.4%Cell biology20.8%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,631Scopus Q1SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.435

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
65

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
4.15

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,560 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations831
3-Year Documents229
Citable Documents213

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1
Pharmacology (medical)Q1
Cancer ResearchQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer International Publishing
Publication Language
English
Frequency
Quarterly
Founding Year
2006
Editorial Address
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
83/333Q1
ONCOLOGY
JCISCIE
114/333Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—5830
2025471322
20244.496715
20235.4821,102
20224.86475826
20214.493762,283
20204.036872,442
20193.683762,161
20183.877671,859
2017—733,035
2016—642,035
2015—551,810
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Targeted Oncology

WoS Q1
2457201820192020202120222023202420254.00
Annual Impact Factor Metric
2025:4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 183235b8-5656-406b-9766-70ff7386c7b8
Database Updated: 2026-10-01